Advertisement
Singapore markets closed
  • Straits Times Index

    3,224.01
    -27.70 (-0.85%)
     
  • S&P 500

    5,247.35
    -1.14 (-0.02%)
     
  • Dow

    39,802.01
    +41.93 (+0.11%)
     
  • Nasdaq

    16,366.93
    -32.59 (-0.20%)
     
  • Bitcoin USD

    71,132.95
    -140.35 (-0.20%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,956.69
    +24.71 (+0.31%)
     
  • Gold

    2,230.40
    +17.70 (+0.80%)
     
  • Crude Oil

    82.40
    +1.05 (+1.29%)
     
  • 10-Yr Bond

    4.2220
    +0.0260 (+0.62%)
     
  • Nikkei

    40,168.07
    -594.66 (-1.46%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • FTSE Bursa Malaysia

    1,530.60
    -7.82 (-0.51%)
     
  • Jakarta Composite Index

    7,288.81
    -21.28 (-0.29%)
     
  • PSE Index

    6,903.53
    +5.36 (+0.08%)
     

1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)

On that note, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) worked together to develop and commercialize their coronavirus vaccine, Comirnaty. In BioNTech's second quarter, practically 100% of its product sales, totaling around $3.3 billion, were attributable to its share of jab revenue.